
CMS Decision Grants Medicare Coverage for Tempus ECG-AF Device
Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine and patient care, today revealed the impact of a recent decision by the Centers for Medicare and Medicaid Services (CMS) to approve reimbursement for cardiac dysfunction assessments using the…












